Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
5.03
Dollar change
+0.12
Percentage change
2.44
%
IndexRUT P/E- EPS (ttm)-1.42 Insider Own34.95% Shs Outstand35.97M Perf Week-9.86%
Market Cap181.33M Forward P/E- EPS next Y-0.60 Insider Trans0.00% Shs Float23.45M Perf Month-19.13%
Income-54.81M PEG- EPS next Q-0.44 Inst Own59.17% Short Float19.82% Perf Quarter-21.28%
Sales13.59M P/S13.34 EPS this Y-1.64% Inst Trans-10.03% Short Ratio19.41 Perf Half Y-29.35%
Book/sh1.03 P/B4.86 EPS next Y58.66% ROA-50.13% Short Interest4.65M Perf Year-42.58%
Cash/sh2.11 P/C2.39 EPS next 5Y- ROE-99.97% 52W Range4.63 - 12.75 Perf YTD-19.78%
Dividend Est.- P/FCF- EPS past 5Y2.15% ROI-70.90% 52W High-60.55% Beta0.06
Dividend TTM- Quick Ratio6.40 Sales past 5Y0.00% Gross Margin68.39% 52W Low8.64% ATR (14)0.37
Dividend Ex-Date- Current Ratio7.08 EPS Y/Y TTM-9.08% Oper. Margin-407.53% RSI (14)41.19 Volatility5.98% 7.09%
Employees136 Debt/Eq1.08 Sales Y/Y TTM- Profit Margin-403.22% Recom1.00 Target Price19.50
Option/ShortYes / Yes LT Debt/Eq1.08 EPS Q/Q-20.34% Payout- Rel Volume0.96 Prev Close4.91
Sales Surprise10.42% EPS Surprise16.43% Sales Q/Q- EarningsMar 13 AMC Avg Volume239.42K Price5.03
SMA20-9.32% SMA50-8.59% SMA200-25.23% Trades Volume229,540 Change2.44%
Date Action Analyst Rating Change Price Target Change
Sep-07-23Initiated Craig Hallum Buy $20
Dec-01-22Initiated Cowen Outperform $25
Oct-21-22Resumed Jefferies Buy $14
Oct-11-22Upgrade SVB Leerink Mkt Perform → Outperform $11
Aug-02-22Initiated Maxim Group Buy $10
Sep-09-21Initiated SVB Leerink Mkt Perform $6
Oct-15-19Initiated H.C. Wainwright Buy $13
Jan-30-19Downgrade Leerink Partners Outperform → Mkt Perform
Mar-16-24 03:57PM
Mar-13-24 05:33PM
04:01PM
Mar-06-24 04:01PM
Feb-28-24 04:01PM
04:05PM Loading…
Jan-04-24 04:05PM
Nov-09-23 01:02PM
Nov-08-23 04:01PM
Nov-01-23 04:05PM
Oct-31-23 08:00AM
Oct-05-23 08:00AM
Sep-19-23 08:00AM
Sep-05-23 08:00AM
Aug-10-23 05:40PM
04:01PM
08:00AM Loading…
Aug-03-23 08:00AM
Aug-01-23 08:00AM
Jul-19-23 08:00AM
Jun-23-23 08:00AM
May-31-23 08:00AM
May-13-23 12:39PM
May-12-23 06:03AM
May-10-23 05:15PM
04:01PM
May-02-23 08:00AM
Mar-27-23 07:12AM
Mar-24-23 06:16AM
Mar-22-23 04:05PM
Mar-15-23 08:00AM
Feb-23-23 08:00AM
08:00AM Loading…
Feb-21-23 08:00AM
Feb-06-23 08:00AM
Jan-31-23 08:00AM
Jan-30-23 08:00AM
Jan-10-23 05:37AM
Dec-29-22 06:47PM
Dec-20-22 12:00PM
09:40AM
Dec-19-22 08:00AM
Dec-14-22 08:00AM
Nov-22-22 08:01AM
Nov-21-22 04:01PM
Nov-09-22 04:30PM
04:05PM
Nov-02-22 08:00AM
Oct-26-22 08:00AM
Oct-11-22 05:32PM
Oct-10-22 09:41AM
09:24AM
08:05AM
08:00AM
Sep-30-22 08:00AM
Sep-01-22 08:00AM
Aug-09-22 07:00AM
Jul-31-22 08:22AM
Jul-13-22 08:00AM
Jul-12-22 08:00AM
Jun-30-22 08:00AM
Jun-07-22 08:00AM
May-24-22 08:00AM
May-17-22 08:00AM
May-16-22 07:10AM
07:00AM
Apr-11-22 07:00AM
Mar-22-22 07:00AM
Mar-01-22 04:05PM
Feb-21-22 09:06AM
Feb-16-22 04:05PM
Feb-03-22 08:00AM
Dec-20-21 04:05PM
Nov-22-21 08:39AM
Nov-09-21 07:00AM
Nov-02-21 08:30AM
Sep-10-21 08:00AM
Sep-01-21 08:00AM
Aug-23-21 10:52AM
Aug-11-21 07:00AM
Jul-13-21 04:08PM
Jul-01-21 08:00AM
May-19-21 08:00AM
May-12-21 08:00AM
Mar-23-21 07:00AM
Feb-25-21 08:00AM
Feb-24-21 03:23AM
Feb-23-21 11:03AM
Feb-17-21 08:00AM
Feb-11-21 08:00AM
Dec-11-20 08:49PM
Dec-10-20 02:18AM
Dec-08-20 12:45PM
10:15AM
Dec-07-20 08:00AM
Nov-19-20 08:00AM
Nov-16-20 07:00AM
Nov-11-20 08:00AM
Oct-08-20 08:00AM
Oct-01-20 07:19AM
Sep-17-20 08:00AM
Sep-03-20 08:00AM
Aug-28-20 02:27PM
scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.